Intuitive Surgical Inc: (NASD: ISRG)

$470.30

-15.58 (-3.21%)

Volume 427,137

May 22 04:00 PM ET

Zacks Rank: 3-Hold

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		468.60 - 489.45
	
		52wk Low - High
		455.18 - 585.67
	
		Previous Close
		485.88
	
		Avg. Volume
		307,119
	
		Industry
		MED INSTRUMENTS
	
		Market Cap
		19.62 B
	
		Div - Yield
		0.00 - 0.00
	
		Beta
		1.62
	
		PE (Forward)
		27.08
	
		Current Year Est.
		17.94
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		2
Buy

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		113 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 04/22/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            27.08
                        
                            PEG Ratio
                            1.54
                        
                            Current Year Est.
                            17.94
                        
                            Current Quarter Estimate
                            4.32
                        
                            Most Accurate Estimate
                            4.32
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            07-18-2013
                        
                            EPS Last Year
                            17.02
                        
                            Expected Earnings Growth
                            17.57%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Intuitive Surgical, Inc. designs and manufactures the da Vinci Surgical System. The da Vinci Surgical System seamlessly translates the surgeon's natural hand movements on instrument controls at a console into corresponding micromovements of instruments positioned inside the patient through small puncture incisions, or ports. The products provide the surgeon with the range of motion and fine tissue control previously possible only with open surgery, while simultaneously allowing the surgeon to work through small ports.   
Full ISRG Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
ISRG Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	4.32	4.24	17.94	20.81
Number of Estimates	12	11	11	12
Low Estimate	4.21	3.96	17.58	20.24
High Estimate	4.51	4.50	18.50	NA
Year Ago EPS	3.75	4.46	15.98	17.94
EPS Growth	15.20%	-4.91%	12.28%	15.96%

More ISRG Estimates

Average Earnings Estimates for ISRG

EPS Growth for ISRG

Industry Analysis

Name	Symbol	Previous Close
INTUITIVE SURG	ISRG	485.88
NATUS MEDICAL	BABY	15.11
CRYOLIFE INC	CRY	6.49
DELCATH SYS INC	DCTH	0.44
GLOBUS MEDICAL	GMED	15.82
HEARTWARE INTL	HTWR	95.05
MELA SCIENCES	MELA	1.09
OXYSURE SYSTEMS	OXYS	0.82
PACIFIC BIOSCI	PACB	2.54
SUNSHINE HEART	SSH	6.02

Sector:Medical>> Industry:MED INSTRUMENTS

COMPARE TICKER vs. Its Peers

Zacks Commentary

Volcano Product Launch at EuroPCR

May 21, 2013

HMA Downgraded to Underperform

May 14, 2013

Neutral Rating Restated for Cepheid

May 13, 2013

Masimo Wins a Major Turkish Client

May 13, 2013

Accuray Lags 3Q Earnings Est

May 08, 2013

MYGN Earnings Easily Beat, Guidance Up

May 08, 2013

Accuray Lags 3Q Earnings Est

May 08, 2013

Reiterate Becton Dickinson at Neutral

May 07, 2013

More ISRG Zacks Commentary

Financials

EPS TTM	17.02
Sales	2,179
Net Income	702
Price/Earnings	28.55
Price/Book	5.20
Price/Cash Flow	25.85
Price/Sales	8.55

More ISRG Financials

News

Intuitive Surgical (ISRG) Trading Near $474.06 Support Level - Freshbrewedmedia

May 22, 2013

One Way MAKO Surgical Could Quadruple - TheMotleyFool

May 22, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG - Pr Newswire

May 22, 2013

Trial involving surgical robot goes to jury in Port Orchard - Mcclatchy-Tribune Information Services -- Unrestricted

May 22, 2013

Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff's Attorney's Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership - Prweb

May 21, 2013

ISRG, AHS, USMO, ISIS, MTL, ATVI Are Seasonally Ripe To Go Up In the Next Five Weeks - M2

May 21, 2013

Intuitive Surgical Set to Possibly Pullback After Yesterday's Rally of 1.35% - Comtex Smartrend(R)

May 21, 2013

Look for Shares of Intuitive Surgical to Potentially Pullback after Yesterday's 1.35% Rise - Comtex Smartrend(R)

May 21, 2013

See All News Stories on ISRG

Broker Recommendations

Current ABR	1.73
ABR (Last Week)	1.73
# of recs in ABR	15
Average Target Price	594.58
Industry Rank by ABR	113 out of 265
Rank in Industry	2 out of 54

More ISRG Broker Recommendations

Day Low - High	468.60 - 489.45
52wk Low - High	455.18 - 585.67
Previous Close	485.88
Avg. Volume	307,119
Industry	MED INSTRUMENTS
Market Cap	19.62 B
Div - Yield	0.00 - 0.00
Beta	1.62
PE (Forward)	27.08
Current Year Est.	17.94
Quarterly Earnings ESP	0.00%

PE (Forward)	27.08
PEG Ratio	1.54
Current Year Est.	17.94
Current Quarter Estimate	4.32
Most Accurate Estimate	4.32
Earnings ESP	0.00%
Next Earnings Report Date	07-18-2013
EPS Last Year	17.02
Expected Earnings Growth	17.57%

Username: Password:

Remember me [?]

Intuitive Surgical Inc: (NASD: ISRG)

$470.30

-15.58 (-3.21%)

Volume 427,137

May 22 04:00 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Medical>> Industry:MED INSTRUMENTS

Zacks Commentary

Financials

News

Broker Recommendations